US Patent Issued to HANMI PHARM. on Oct. 7 for "Therapeutic enzyme fusion protein having a novel structure and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,328, issued on Oct. 7, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Therapeutic enzyme fusion protein having a novel structure and use thereof" was invented by Eui Joon Jung (Hwaseong-si, South Korea), Jin Young Kim (Hwaseong-si, South Korea), In Young Choi (Hwaseong-si, South Korea) and Sung Youb Jung (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A fusion protein of a dimeric therapeutic enzyme and an immunoglobulin Fc region, a preparation method thereof, and a composition containing the fusion protein are disclosed."

The patent was filed on Dec. 21, 2018, under Application No. 16/955,525.

*For fur...